FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer

Akeso reports updated data on cadonilimab combination therapy in PD-(L)1 inhibitor-resistant advanced NSCLC data

AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management

GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure

Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences

GXO appointed to manage NHS England bowel cancer home testing kits

Hoth Therapeutics deploys OpenClaw AI platform for drug discovery

Eisai and Nuvation Bio report taletrectinib MAA validated by European regulator

Iterion Therapeutics reports first patient dosed in phase 1/2 trial of tegavivint in colorectal cancer

SciTech Development reports early-stage clinical data from Phase 1a trial of ST-001 nanoFenretinide at USCLC Annual Workshop 2026

Clarity Pharmaceuticals signs copper-64 manufacturing agreement with Theragenics